Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · IEX Real-Time Price · USD
0.835
+0.025 (3.05%)
At close: Jul 26, 2024, 4:00 PM
0.830
-0.005 (-0.56%)
After-hours: Jul 26, 2024, 7:15 PM EDT

Hoth Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2017
Selling, General & Admin
4.554.216.136.574.415.06
Upgrade
Research & Development
3.013.484.937.532.892.12
Upgrade
Other Operating Expenses
-----0.54
Upgrade
Operating Expenses
7.557.6911.0714.17.37.71
Upgrade
Operating Income
-7.55-7.69-11.07-14.1-7.3-7.71
Upgrade
Interest & Investment Income
0.040.050.07-0.030.01
Upgrade
Currency Exchange Gain (Loss)
------0
Upgrade
Other Non Operating Income (Expenses)
--0.45-0.060.02-
Upgrade
EBT Excluding Unusual Items
-7.52-7.64-10.55-14.16-7.25-7.71
Upgrade
Gain (Loss) on Sale of Investments
-0.19-0.2-0.82-0.150.050
Upgrade
Pretax Income
-7.7-7.85-11.37-14.31-7.2-7.7
Upgrade
Net Income
-7.7-7.85-11.37-14.31-7.2-7.7
Upgrade
Preferred Dividends & Other Adjustments
--0---
Upgrade
Net Income to Common
-7.7-7.85-11.37-14.31-7.2-7.7
Upgrade
Shares Outstanding (Basic)
431100
Upgrade
Shares Outstanding (Diluted)
431100
Upgrade
Shares Change (YoY)
146.33%184.69%34.07%80.63%34.90%82.16%
Upgrade
EPS (Basic)
-1.98-2.30-9.50-16.02-14.56-21.02
Upgrade
EPS (Diluted)
-1.98-2.30-9.50-16.02-14.56-21.02
Upgrade
Free Cash Flow
-7.88-8.45-9.3-12.09-6.13-4.95
Upgrade
Free Cash Flow Per Share
-2.03-2.48-7.76-13.54-12.40-13.50
Upgrade
EBITDA
----14.1-7.3-7.71
Upgrade
D&A For EBITDA
---000
Upgrade
EBIT
-7.55-7.69-11.07-14.1-7.3-7.71
Upgrade
Source: S&P Capital IQ. Standard template.